U.S. Life Science investment favors Biotech and AI/Digital Health companies

Percent share of life science investment in the U.S. for the following categories Biotech, Al/Digital Health, Medical Devices, Food & Agriculture Tech, Diagnostics from 2014 to 2023 year-to-date
  • Over the last ten years, investment into the life science industry has predominantly been focused on biotech, with a notable increase for AI/Digital Health companies. Together, these two subsectors have accounted for over 78% of life science investment on average since the start of 2014.
  • Increased investment into AI/Digital Health-oriented life science companies has demand implications related to workplace infrastructure that can accommodate a heavy amount of computing power rather than traditional laboratory space or  “wet lab”.

Get market intel